Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin on Endothelial Function in CAD and Early Diabetes
NCT02350478Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jul 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Graz. Primary endpoint: Flow Mediated Dilatation at 12 weeks. Started Jul 2013; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02350478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350478.